Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-12-27 17:08:32
Reporting Period:
Accepted Time:
2017-12-27 17:08:32
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1378624 Cellular Biomedicine Group Inc. CBMG Biological Products, (No Disgnostic Substances) (2836) 861032927
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569983 Tony Liu 19925 Stevens Creek Blvd.
Suite 100
Cupertino CA 95014
Ceo, Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-22 29,167 $12.00 139,167 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The shares were purchased pursuant to that certain Share Purchase Agreement, dated December 15, 2017, by and among the issuer, the reporting person and two other officers of the issuer. The issuance of the shares was made in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.
  2. The amount does not include shares of common stock granted as part of the Restricted Stock Units under the Cellular Biomedicine Group, Inc. 2014 Stock Incentive Plan, which grant has been previously reported on the reporting person's Form 4.